Taking a look at stock we notice that its last check on previous day was $5.55 with its price kept floating in the range of $5.33 and $5.69 on the day. Considering stock’s 52-week price range provides that DERM hit a high price of $8.11 and saw its price falling to a low level of $2.85 during that period. Over a period of past 1-month, stock came subtracting -3.31% in its value.
With its current market valuation of $115.94 million, Journey Medical Corp is set to declare its quarterly results in December. Analysts are in estimates of 0 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to 0 for current year with estimates of that growing to 0 in next year.
Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of 14.21M. They suggested that in the process company could generate revenue of as low as 13.26M which could climb up to 14.8M to hit a high. The average estimate is representing a decrease of -6.84% in sales growth from that of posted by the company in the same quarter of last year. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of 56.72M in current fiscal year, which will be -28.36% less from revenue generated by the company last year.
In contrast, when we review DERM stock’s current outlook then short term indicators are assigning it an average of 50% Buy, while medium term indicators are categorizing the stock at an average of 50% Buy. Long term indicators are suggesting an average of 100% Buy for it.
According to ratings assigned by 1 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; 0 of them are recommending Journey Medical Corp (DERM) as a Hold, while 1 are in view that stock is a Buy. Recommendation by 0 analysts for the stock is an Underweight while number of those analysts who rated the stock as an Overweight is 0, whereas 0 of them are considering the stock as a Sell. When taken as whole, stock gets a rating of Overweight and that encourages the investors to exploit the opportunity and build their stake up in the company.
Digging deeper we become aware of the PEG ratio of the DERM stock which is currently positioned at 0. It further provides that stock’s current price level is 2.07% away from its 20-day simple moving average and is -2.15% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 51.07 while volatility remained at 7.83% over the past week which changes to 8.22% when measuring it over the past month. Beta is valued at 0.88, while measure of average true range or ATR is currently at 0.43.
Having a second look at Journey Medical Corp (NASDAQ:DERM) provides that stock’s average daily trading volume for 3 months was 91.24K, while it jumped to 83000 when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 13.32 million.
The percentage of outstanding shares held by the insiders is 51.41% while it is 10.38% for the institutional holders. The figures also indicate that as of 2024-11-15, number of stock’s short shares was 66232.0 which implies a short ratio of 0.46. This shows down a 148.00 of Short Interest in company’s outstanding shares on the day. In November the standing of shares short improved as it was 76691.0 in the previous month. Subtraction of -3.65% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
